Abliva - CEO Ellen Donnelly talks about the positive interim analysis in the FALCON study

(3:24)

Abliva leads the way with potential mitochondrial disease treatment

(12:12)

Abliva - on track to deliver interim data H1 2024

(7:22)

BioStock | Abliva on the phase II-study | March 2023

(5:40)

Abliva participates in World Mitochondrial Disease Week 2023

(1:8)

Abliva - Review of Interim Analysis

(14:11)

CEO comment from Abliva's Annual General Meeting 2021

(8:25)

BioStock | NLSDays | Abliva

(1:31)

BioStock Life Science Summit 2021 | Abliva

(22:26)

Pharming koopt met KL1333 van Abliva kans op blockbuster

(4:5)

Companies focused on employee wellbeing, says AXA CEO

(2:50)

How to give company presentation | How to give company Introduction to client | BNI education slot

(10:20)

Full Year Earnings 2021with our CEO, Thomas Buberl | AXA

(3:19)

Abarceo Pharma | BioStock Life Science Summit 2024

(5:27)

Fintech Affirm Outpacing Industry Rivals

(5:34)

APhA 2024 Announcement

(2:26)

RASHAAD LAMBERT: SVP of Forbes and Founder of For(bes) The Culture | NeverFold Podcast Ep.1

(51:3)

Aurinia Pharmaceuticals CEO: Speculative Savior? | Mad Money | CNBC

(6:58)

2020 Half Year Earnings: Interview with Thomas Buberl, CEO of AXA

(4:50)

Abliva – Aktiedagen Stockholm 16 mars 2021

(30:8)

BioStock | Abliva | Financing round | June 2022

(6:16)

BioStock Investor Meeting | Abliva | March 2023

(18:36)

Abliva | BioStock Life Science Summit 2024

(15:5)

Abliva's CEO Ellen Donnelly presents the company at Swiss Nordic Bio 2021

(7:8)

BioStock Live | Abliva March 9 2021

(19:7)

Abliva – Kvinnokvällen Göteborg 31 augusti 2021

(28:6)

Abliva – Stora Aktiedagen Stockholm 29 november 2022

(28:39)

Abliva - Light Up for Mito during World Mitochondrial Disease Week 2024

(1:14)

Abliva – Temadag Life Science 31 augusti 2022

(25:31)